Study Synopsis In patients classified as HBR, there was a significant reduction in the primary endpoint (p=0.043) when comparing physiology-guided complete revascularization to the culprit-only strategy. The study was conducted across 34 participating sites spanning Italy, Spain, and Poland covering 1445 patients from July
Study Synopsis • The findings will impact the interventional treatment of High Bleeding Risk patients. • Data from 732 patients across 11 Dutch centres For immediate release SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on innovative patient care in cardiovascular segment, today announced positive
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
